Alkermes plc.
ALKS
60 insider filings · Latest: Oct 8, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Oct 2, 2026 | Oct 2 10:22 PM | David Joseph GaffinEVP, CLO, Alkermes, Inc. | Sale | 2,034 | $41.03 | $83.5K | 221,388(D) | View → |
| Oct 2, 2026 | Oct 2 8:04 PM | Gaffin David Joseph | Proposed Sale | 2,034 | $41.03 | $83.5K | — | View → |
| Sep 3, 2026 | Sep 3 10:32 PM | David Joseph GaffinEVP, CLO, Alkermes, Inc. | Sale | 2,034 | $48.01 | $97.7K | 223,422(D) | View → |
| Sep 3, 2026 | Sep 3 8:58 PM | Gaffin David Joseph | Proposed Sale | 2,034 | $48.01 | $97.7K | — | View → |
| Sep 1, 2026 | Sep 1 11:08 PM | Craig C. HopkinsonEVP R&D, Chief Medical Officer | Sale | 9,000 | $46.99 | $422.9K | 65,389(D) | View → |
| Sep 1, 2026 | Sep 1 8:10 PM | Hopkinson Craig C. | Proposed Sale | 9,000 | $46.99 | $422.9K | — | View → |
| Aug 17, 2026 | Aug 17 10:53 PM | Christian Todd NicholsSVP, Chief Commercial Officer | Sale | 7,576 | $49.23 | $372.9K | 102,193(D) | View → |
| Aug 17, 2026 | Aug 17 8:50 PM | Nichols Christian Todd | Proposed Sale | 7,576 | $49.23 | $372.9K | — | View → |
| Aug 3, 2026 | Aug 3 11:16 PM | Nancy Lynn Snyderman MDDirector | Sale | 44,472 | $50.35 | $2.2M | 15,395(D) | View → |
| Aug 3, 2026 | Aug 3 11:12 PM | Craig C. HopkinsonEVP R&D, Chief Medical Officer | Sale | 9,000 | $48.58 | $437.2K | 69,389(D) | View → |
| Aug 3, 2026 | Aug 3 11:09 PM | David Joseph GaffinEVP, CLO, Alkermes, Inc. | Sale | 2,034 | $48.58 | $98.8K | 225,456(D) | View → |
| Aug 3, 2026 | Aug 3 8:34 PM | snyderman nancy lynn MD | Proposed Sale | 44,472 | $50.35 | $2.2M | — | View → |
| Aug 3, 2026 | Aug 3 8:32 PM | Gaffin David Joseph | Proposed Sale | 2,034 | $48.58 | $98.8K | — | View → |
| Aug 3, 2026 | Aug 3 8:31 PM | Hopkinson Craig C. | Proposed Sale | 9,000 | $48.58 | $437.2K | — | View → |
| Jul 6, 2026 | Jul 6 8:48 PM | David Joseph GaffinEVP, CLO, Alkermes, Inc. | Sale | 2,034 | $54.03 | $109.9K | 227,490(D) | View → |
| Jul 6, 2026 | Jul 6 8:18 PM | Gaffin David Joseph | Proposed Sale | 2,034 | $54.03 | $109.9K | — | View → |
| Jul 1, 2026 | Jul 1 10:29 PM | Craig C. HopkinsonEVP R&D, Chief Medical Officer | Sale | 9,000 | $51.51 | $463.6K | 73,389(D) | View → |
| Jul 1, 2026 | Jul 1 8:12 PM | Hopkinson Craig C. | Proposed Sale | 9,000 | $51.51 | $463.6K | — | View → |
| Jun 12, 2026 | Jun 13 12:04 AM | Christopher I WrightDirector | Sale | 2,000 | $45.10 | $90.2K | 25,680(D) | View → |
| Jun 12, 2026 | Jun 12 8:19 PM | Wright Christopher I | Proposed Sale | 2,000 | $45.10 | $90.2K | — | View → |
Page 1 of 4
Next →
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Feb 26, 2026 | Feb 27 9:39 PM | Blair Curtis JacksonEVP, Chief Operating Officer | Option Exercise | 8,322 | — | 16,645(D) | View → |
| Feb 26, 2026 | Feb 27 9:38 PM | Craig C. HopkinsonEVP R&D, Chief Medical Officer | Option Exercise | 6,866 | — | 13,732(D) | View → |
| Feb 26, 2026 | Feb 27 9:37 PM | David Joseph GaffinEVP, CLO, Alkermes, Inc. | Option Exercise | 6,866 | — | 13,732(D) | View → |
| Feb 23, 2026 | Feb 25 10:49 PM | Samuel Joseph ParisiVP, Finance (Interim PAO) | Option Exercise | 2,283 | — | 2,284(D) | View → |
| Feb 23, 2026 | Feb 25 10:48 PM | Christian Todd NicholsSVP, Chief Commercial Officer | Option Exercise | 6,407 | — | 6,408(D) | View → |
| Feb 23, 2026 | Feb 25 10:47 PM | Blair Curtis JacksonEVP, Chief Operating Officer | Option Exercise | 8,738 | — | 8,738(D) | View → |
| Feb 23, 2026 | Feb 25 10:46 PM | Craig C. HopkinsonEVP R&D, Chief Medical Officer | Option Exercise | 7,689 | — | 7,690(D) | View → |
| Feb 23, 2026 | Feb 25 10:44 PM | David Joseph GaffinEVP, CLO, Alkermes, Inc. | Option Exercise | 7,689 | — | 7,690(D) | View → |
| Feb 19, 2026 | Feb 20 9:25 PM | Samuel Joseph ParisiVP, Finance (Interim PAO) | Option Exercise | 2,991 | — | 8,974(D) | View → |
| Feb 18, 2026 | Feb 20 9:25 PM | Samuel Joseph ParisiVP, Finance (Interim PAO) | Option Exercise | 2,034 | — | 0(D) | View → |
| Feb 19, 2026 | Feb 20 9:24 PM | Christian Todd NicholsSVP, Chief Commercial Officer | Option Exercise | 6,045 | — | 18,137(D) | View → |
| Feb 18, 2026 | Feb 20 9:24 PM | Christian Todd NicholsSVP, Chief Commercial Officer | Option Exercise | 6,355 | — | 0(D) | View → |
| Feb 19, 2026 | Feb 20 9:23 PM | Blair Curtis JacksonEVP, Chief Operating Officer | Option Exercise | 9,300 | — | 27,903(D) | View → |
| Feb 18, 2026 | Feb 20 9:23 PM | Blair Curtis JacksonEVP, Chief Operating Officer | Option Exercise | 8,897 | — | 0(D) | View → |
| Feb 19, 2026 | Feb 20 9:22 PM | Craig C. HopkinsonEVP R&D, Chief Medical Officer | Option Exercise | 7,673 | — | 23,019(D) | View → |
| Feb 18, 2026 | Feb 20 9:22 PM | Craig C. HopkinsonEVP R&D, Chief Medical Officer | Option Exercise | 8,897 | — | 0(D) | View → |
| Feb 19, 2026 | Feb 20 9:20 PM | David Joseph GaffinEVP, CLO, Alkermes, Inc. | Option Exercise | 7,673 | — | 23,019(D) | View → |
| Feb 18, 2026 | Feb 20 9:20 PM | David Joseph GaffinEVP, CLO, Alkermes, Inc. | Option Exercise | 6,355 | — | 0(D) | View → |
| Feb 2, 2026 | Feb 3 1:52 AM | Craig C. HopkinsonEVP R&D, Chief Medical Officer | Option Exercise | 5,000 | $19.34 | 26,356(D) | View → |
| Feb 2, 2026 | Feb 3 1:48 AM | Shane CookeDirector | Option Exercise | 61,200 | $31.64 | 0(D) | View → |
← Previous
Page 3 of 3